1. 1

2. 2

3. 3 Definition Definition Osteoporosis:A condition of skeletal fragility characterized by reduced bone mass and microarchitectural deterioration of bone tissue, with a consequent increase in bone fragility and susceptibility to fractures Osteoporosis:A condition of skeletal fragility characterized by reduced bone mass and microarchitectural deterioration of bone tissue, with a consequent increase in bone fragility and susceptibility to fractures Osteopenia – Reduction in bone mass which can lead to full osteoporosis (“At Risk”) Osteopenia – Reduction in bone mass which can lead to full osteoporosis (“At Risk”)

4. 4 Osteoporosis(Definition) Normal boneOsteoporosis

5. 5 Osteoporosis (Importance) WHO :The 4 more important enemies of human : 1-Cancer 2-Cardiovascular dis. 3-Cerebrovascular dis. 4-Osteoporosis WHO :The 4 more important enemies of human : 1-Cancer 2-Cardiovascular dis. 3-Cerebrovascular dis. 4-Osteoporosis Osteoporosis mortality = Breast cancer +uterine cancer + ovary cancer mortality Osteoporosis mortality = Breast cancer +uterine cancer + ovary cancer mortality

6. 6 Osteoporosis ( Epidemiology)  Affects 200 million women worldwide - 1/3 of women aged 60 to 70 - 2/3 of women aged 80 or older  Approximately 20-25% of women over the age of 50 have one or more vertebral fractures

7. 7 Osteoporosis(Epidemiology)  10 million people have osteoporosis in USA (8 mil women, 2 mil men)  18 million people or more have low bone mass(USA)  Most prevalent among postmenopausal woman but can occur at any age  24% of hip fracture patients age 50 and older die in one year following fx  Only 1/3 fully regain their prefracture level of independence  Cost > $20 billion/yr(USA)

8. Incidence Rates for Vertebral, Wrist & Hip Fractures in Women after Age 50 50 60 70 80 40 30 20 10 Vertebrae Hip Wrist Age (Years) Annual incidence per 1000 women

9. 9 Osteoporosis(Epidemiology) Fractures Fractures  1.5 million fx/yr(USA)  300,000 hip  700,000 vertebral  250,000 wrist  250,000 at other sites

10. Osteoporotic Fractures in Women: Comparison with Other Diseases 1 500 000* 0 500 1000 1500 2000 Osteoporotic Fractures * annual incidence all ages † annual estimate women 29+ ‡ annual estimate women 30+ § 1996 new cases, all ages 513 000 † 228 000 ‡ 184 300 § 750 000 vertebral 250 000 other sites 250 000 forearm 250 000 hip Heart Attack StrokeBreast Cancer Annual incidence x 1000

11. 11 Osteoporosis( Pathophysiology) Peak bone mass is achieved by men and women in the middle of the third decade of life. After a plateau period, there begins a period of net bone loss (about 0.3% to 0.5% a year). With menopause, women may lose bone at the rate of 3% to 5% a year.

12. 12 Risk Factors in Osteoporosis Nonmodifiable Nonmodifiable »History of fracture in first degree relative. »Caucasian race »Advanced Age »Female sex Potentially Modifiable –Smoking – Low Body Weight (<127 lbs) –Estrogen deficiency: Early Menopause (<45 yr) or Prolonged amenorrhea –Excess alcohol intake –Sedentary lifestyle –Low calcium intake –Inadequate physical activity –Poor health, poor eyesight and recurrent falls.

13. Pathogenesis of Estrogen Deficiency and Bone Loss Estrogen loss triggers increases in IL-1, IL-6, and TNF due to: Estrogen loss triggers increases in IL-1, IL-6, and TNF due to: –Reduced suppression of gene transcription of IL-6 and TNF –Increased number of monocytes Increased cytokines lead to increased osteoclast development and lifespan

14. Bone Resorption

15. 15 Osteoporosis Clinical manifestation

16. 16 No clinical manifestation until there is a fracture Osteoporosis is a silent Thief

17. THE TIP OF THE ICEBERG

18. 18 The most common fractures  Vertebral fracture  Hip fracture  Distal of radius fracture

19. 19 Vertebral fracture  The most common fracture  Usually spontaneous  Thoracolumbar junction

20. 20 vertebral fracture vertebral fracture short-term outcome  May be asymptomatic  Acute onset of pain(shurp or dull)  Pain may radiates into the anterior abdomen  Pain radiation into the legs is rare  Movement aggravate the discomfort  Acute episode resolve after 4-6 weeks

21. 21 vertebral fracture long-term morbidity  Chronic pain  Thoracic kyphosis(Dowager’s hump)  Height loss

22. 22

23. Vertebral Fracture Cascade

24. 24 Hip fracture  Core of the osteoporosis probleme  Usually follow falls  Sudden pain and disability  Leading to hospitalisation  High morbidity and mortality

25. 25  Usually follow falls  Localizied pain,swelling and disability

26. Diagnosis Lab. tests are normal in primary osteoporosis

27. Diagnosis Bone Densitometry Bone Densitometry Bone X-Ray Bone X-Ray

28. 28 Types of BMD testing   DEXA (Dual –energy x-ray absorptiometry).   Gold Standard   Measures BMD in spine, hip, or wrist   Completed in a few minutes   Radiation exposure less than 1/10 of standard x-ray   Ultrasound densitometry   Measures BMD in heel, patella   Cost-effective   Poor correlation between US and DXA

29. 29

30. BMD measurement:

31. 31 T scores vs. Z scores  T score  Z score

32. 32 WHO, Guidelines for Preclinical Evaluation and Clinical Trials in Osteoporosis, 1998. T-Score World Health Organization (WHO) Osteoporosis Guidelines

33. When to perform BMD All postmenopausal women <65 yr who have one or more additional risk factors for osteoporosis (besides menopause) All postmenopausal women <65 yr who have one or more additional risk factors for osteoporosis (besides menopause) All women >65 All women >65 To document reduced bone density in patients with vertebral abnormalities or osteopenia on radiographs To document reduced bone density in patients with vertebral abnormalities or osteopenia on radiographs Estrogen-deficient women Estrogen-deficient women 33

34. When to perform BMD Women who have been on estrogen replacement Women who have been on estrogen replacement Glucocorticoid-treated individuals Glucocorticoid-treated individuals Hyperparathyroidism Hyperparathyroidism 34

35. 35 Radiographic Assessment Vaccaro 2003

36. 36

37. Vertebral Fractures Semi-quantitative reading / visual scoring Genant et al., J Bone Miner Res 1993, 8:137 Normal (Grade 0) Wedge fractureBiconcave fracture Crush fracture Mild fracture (Grade 1, ~20-25%) Moderate fracture (Grade 2, ~25-40%) Severe fracture (Grade 3, ~40%)

38. 38 Work-up  BMD testing  Screen for secondary causes  CBC, ESR  Creatinin  Serum calcium, phosphorus, alk phos  PTH if calcium is high (hyperparathyroidism)  25-hydroxyvitamin D if low ca, low phos and high alk. phos (osteomalacia)  Thyroid function tests (thyrotoxicosis)  SPEP (multiple myeloma)

39. 39 Treatment Preventive Measures  Calcium  Vitamin D (400-800 IU)  Regular weight bearing exercise  Weight lifting, walking, jogging, tennis  Smoking cessation  Minimize etoh  Fall prevention

40. 40 Calcium Requirements Recommended elemental calcium needs by age in mg/ca/day Children 800 Up to age 24 1200-1500 Women 25 –50 1000 Pregnant and breast feeding 1200-1500 Women over 50 Taking ERT 1000 Taking ERT 1000 Not taking ERT 1500 Women over 65 1500

41. 41 Treatment Calcium Calcium Exercise Exercise Vit D Vit D Biphosphonates ++ Biphosphonates ++ Calcitonin Calcitonin Raloxifen Raloxifen Anabolic steroids (increase bone mass but seldom used) Anabolic steroids (increase bone mass but seldom used) Relief of symptoms Relief of symptoms